Clinical Trial Update: Neurobiomarker for Prism Adaptation Treatment Response [NA]

View source ↗

Summary

A clinical trial evaluating a neurobiomarker for prism adaptation treatment response in perceptual disorders and stroke has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perceptual Disorders
• Stroke

Snippet

Sponsor: University of Utah | Conditions: Perceptual Disorders, Stroke | NA | Status: WITHDRAWN